HEADER OXIDOREDUCTASE 25-MAR-16 5IZC TITLE TRYPANOSOMA BRUCEI PTR1 IN COMPLEX WITH INHIBITOR F032 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PTERIDINE REDUCTASE; COMPND 3 CHAIN: A, B, D; COMPND 4 EC: 1.5.1.33; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: ONLY IN SUBUNIT C CYS60 HAS BEEN OXIDIZED TO OCS. IN COMPND 7 ALL SUBUNITS CYS168 HAS BEEN CHEMICALLY MODIFIED BY BME; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PTERIDINE REDUCTASE; COMPND 10 CHAIN: C; COMPND 11 EC: 1.5.1.33; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: ONLY IN SUBUNIT C CYS60 HAS BEEN OXIDIZED TO OCS. IN COMPND 14 ALL SUBUNITS CYS168 HAS BEEN CHEMICALLY MODIFIED BY BME SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI; SOURCE 3 ORGANISM_TAXID: 5702; SOURCE 4 GENE: PTR1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI; SOURCE 9 ORGANISM_TAXID: 5702; SOURCE 10 GENE: PTR1; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 12 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS TRYPANOSOMA BRUCEI, PTERIDINE REDUCTASE, INHIBITOR, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.POZZI,G.LANDI,F.DI PISA,S.MANGANI REVDAT 4 10-JAN-24 5IZC 1 REMARK REVDAT 3 18-OCT-17 5IZC 1 JRNL REVDAT 2 27-SEP-17 5IZC 1 AUTHOR JRNL REVDAT 1 05-APR-17 5IZC 0 JRNL AUTH P.LINCIANO,A.DAWSON,I.POHNER,D.M.COSTA,M.S.SA, JRNL AUTH 2 A.CORDEIRO-DA-SILVA,R.LUCIANI,S.GUL,G.WITT,B.ELLINGER, JRNL AUTH 3 M.KUZIKOV,P.GRIBBON,J.REINSHAGEN,M.WOLF,B.BEHRENS, JRNL AUTH 4 V.HANNAERT,P.A.M.MICHELS,E.NERINI,C.POZZI,F.DI PISA,G.LANDI, JRNL AUTH 5 N.SANTAREM,S.FERRARI,P.SAXENA,S.LAZZARI,G.CANNAZZA, JRNL AUTH 6 L.H.FREITAS-JUNIOR,C.B.MORAES,B.S.PASCOALINO,L.M.ALCANTARA, JRNL AUTH 7 C.P.BERTOLACINI,V.FONTANA,U.WITTIG,W.MULLER,R.C.WADE, JRNL AUTH 8 W.N.HUNTER,S.MANGANI,L.COSTANTINO,M.P.COSTI JRNL TITL EXPLOITING THE 2-AMINO-1,3,4-THIADIAZOLE SCAFFOLD TO INHIBIT JRNL TITL 2 TRYPANOSOMA BRUCEI PTERIDINE REDUCTASE IN SUPPORT OF JRNL TITL 3 EARLY-STAGE DRUG DISCOVERY. JRNL REF ACS OMEGA V. 2 5666 2017 JRNL REFN ESSN 2470-1343 JRNL PMID 28983525 JRNL DOI 10.1021/ACSOMEGA.7B00473 REMARK 2 REMARK 2 RESOLUTION. 1.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 74.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 69153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3668 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.92 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5055 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE SET COUNT : 247 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7292 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 262 REMARK 3 SOLVENT ATOMS : 573 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.151 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.112 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.100 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7775 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 7481 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10629 ; 2.021 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): 17116 ; 1.060 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1013 ; 8.554 ; 5.030 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 288 ;34.532 ;24.167 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1193 ;14.108 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 46 ;16.427 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1276 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8807 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1727 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3968 ; 1.763 ; 1.858 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3964 ; 1.758 ; 1.857 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4943 ; 2.708 ; 2.764 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5IZC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000219676. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 - 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73011 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.920 REMARK 200 RESOLUTION RANGE LOW (A) : 74.364 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.33300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4WCD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TBPTR1 6-10 MG/ML IN 20 MM TRIS-HCL PH REMARK 280 7.5 AND 10 MM DTT OR BME) AND PRECIPITANT (1.5-2.5 M SODIUM REMARK 280 ACETATE AND 0.1 M SODIUM CITRATE PH 5), VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.72150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -133.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 104 REMARK 465 GLY A 105 REMARK 465 ASP A 106 REMARK 465 HIS A 107 REMARK 465 GLU A 108 REMARK 465 ASP A 109 REMARK 465 ASN A 110 REMARK 465 SER A 111 REMARK 465 ASN A 112 REMARK 465 LYS A 143 REMARK 465 GLY A 144 REMARK 465 THR A 145 REMARK 465 ASN A 146 REMARK 465 PRO A 147 REMARK 465 ASN A 148 REMARK 465 CYS A 149 REMARK 465 THR A 150 REMARK 465 SER A 151 REMARK 465 MET B 1 REMARK 465 GLN B 104 REMARK 465 GLY B 105 REMARK 465 ASP B 106 REMARK 465 HIS B 107 REMARK 465 GLU B 108 REMARK 465 ASP B 109 REMARK 465 ASN B 110 REMARK 465 SER B 111 REMARK 465 ASN B 112 REMARK 465 GLY B 113 REMARK 465 LYS B 143 REMARK 465 GLY B 144 REMARK 465 THR B 145 REMARK 465 ASN B 146 REMARK 465 PRO B 147 REMARK 465 ASN B 148 REMARK 465 CYS B 149 REMARK 465 THR B 150 REMARK 465 SER B 151 REMARK 465 SER B 152 REMARK 465 GLN C 104 REMARK 465 GLY C 105 REMARK 465 ASP C 106 REMARK 465 HIS C 107 REMARK 465 GLU C 108 REMARK 465 ASP C 109 REMARK 465 ASN C 110 REMARK 465 SER C 111 REMARK 465 ASN C 112 REMARK 465 GLY C 113 REMARK 465 LYS C 143 REMARK 465 GLY C 144 REMARK 465 THR C 145 REMARK 465 ASN C 146 REMARK 465 PRO C 147 REMARK 465 ASN C 148 REMARK 465 CYS C 149 REMARK 465 THR C 150 REMARK 465 SER C 151 REMARK 465 VAL C 211 REMARK 465 ALA C 212 REMARK 465 MET C 213 REMARK 465 GLY C 214 REMARK 465 GLU C 215 REMARK 465 GLU C 216 REMARK 465 GLU C 217 REMARK 465 LYS C 218 REMARK 465 MET D 1 REMARK 465 GLN D 104 REMARK 465 GLY D 105 REMARK 465 ASP D 106 REMARK 465 HIS D 107 REMARK 465 GLU D 108 REMARK 465 ASP D 109 REMARK 465 ASN D 110 REMARK 465 SER D 111 REMARK 465 ASN D 112 REMARK 465 GLY D 113 REMARK 465 LYS D 143 REMARK 465 GLY D 144 REMARK 465 THR D 145 REMARK 465 ASN D 146 REMARK 465 PRO D 147 REMARK 465 ASN D 148 REMARK 465 CYS D 149 REMARK 465 THR D 150 REMARK 465 SER D 151 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 39 CG CD OE1 OE2 REMARK 470 LYS A 50 CD CE NZ REMARK 470 GLU A 51 CG CD OE1 OE2 REMARK 470 GLN A 250 CG CD OE1 NE2 REMARK 470 LYS B 50 CE NZ REMARK 470 GLU B 74 OE1 OE2 REMARK 470 MET C 1 CG SD CE REMARK 470 GLU C 2 CG CD OE1 OE2 REMARK 470 LYS C 50 CG CD CE NZ REMARK 470 ASP C 219 CG OD1 OD2 REMARK 470 LYS C 220 CG CD CE NZ REMARK 470 ARG C 223 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 224 CG CD CE NZ REMARK 470 GLU D 2 CG CD OE1 OE2 REMARK 470 GLU D 39 CG CD OE1 OE2 REMARK 470 LYS D 50 CG CD CE NZ REMARK 470 GLU D 216 CG CD OE1 OE2 REMARK 470 GLU D 217 CG CD OE1 OE2 REMARK 470 ARG D 223 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 198 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG B 198 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ASP D 62 CB - CG - OD1 ANGL. DEV. = 6.1 DEGREES REMARK 500 ARG D 222 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ASP D 260 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP D 260 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 14 -132.98 60.89 REMARK 500 HIS A 35 -75.24 -114.17 REMARK 500 ALA A 128 -53.99 -143.83 REMARK 500 CYS A 160 -155.80 -101.19 REMARK 500 SER A 207 -138.76 -118.27 REMARK 500 ARG B 14 -128.97 56.44 REMARK 500 HIS B 35 -72.45 -115.61 REMARK 500 ALA B 61 138.88 -173.08 REMARK 500 ALA B 128 -51.71 -134.90 REMARK 500 CYS B 160 -154.89 -99.76 REMARK 500 SER B 207 -141.16 -117.24 REMARK 500 ARG C 14 -121.31 49.53 REMARK 500 HIS C 35 -70.01 -119.39 REMARK 500 SER C 37 62.68 -105.73 REMARK 500 ALA C 128 -45.85 -135.19 REMARK 500 CYS C 160 -158.94 -104.66 REMARK 500 PHE C 171 44.54 -108.65 REMARK 500 SER C 207 -152.25 -107.03 REMARK 500 LEU C 208 118.96 -35.88 REMARK 500 ARG D 14 -127.59 49.56 REMARK 500 HIS D 35 -73.16 -112.73 REMARK 500 ALA D 128 -52.78 -141.39 REMARK 500 CYS D 160 -156.66 -101.98 REMARK 500 PHE D 171 41.23 -109.16 REMARK 500 SER D 207 -145.54 -106.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6F4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6F4 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6F4 C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6F4 D 302 DBREF 5IZC A 1 268 UNP O76290 O76290_TRYBB 1 268 DBREF 5IZC B 1 268 UNP O76290 O76290_TRYBB 1 268 DBREF 5IZC C 1 268 UNP O76290 O76290_TRYBB 1 268 DBREF 5IZC D 1 268 UNP O76290 O76290_TRYBB 1 268 SEQRES 1 A 268 MET GLU ALA PRO ALA ALA VAL VAL THR GLY ALA ALA LYS SEQRES 2 A 268 ARG ILE GLY ARG ALA ILE ALA VAL LYS LEU HIS GLN THR SEQRES 3 A 268 GLY TYR ARG VAL VAL ILE HIS TYR HIS ASN SER ALA GLU SEQRES 4 A 268 ALA ALA VAL SER LEU ALA ASP GLU LEU ASN LYS GLU ARG SEQRES 5 A 268 SER ASN THR ALA VAL VAL CYS GLN ALA ASP LEU THR ASN SEQRES 6 A 268 SER ASN VAL LEU PRO ALA SER CYS GLU GLU ILE ILE ASN SEQRES 7 A 268 SER CYS PHE ARG ALA PHE GLY ARG CYS ASP VAL LEU VAL SEQRES 8 A 268 ASN ASN ALA SER ALA PHE TYR PRO THR PRO LEU VAL GLN SEQRES 9 A 268 GLY ASP HIS GLU ASP ASN SER ASN GLY LYS THR VAL GLU SEQRES 10 A 268 THR GLN VAL ALA GLU LEU ILE GLY THR ASN ALA ILE ALA SEQRES 11 A 268 PRO PHE LEU LEU THR MET SER PHE ALA GLN ARG GLN LYS SEQRES 12 A 268 GLY THR ASN PRO ASN CYS THR SER SER ASN LEU SER ILE SEQRES 13 A 268 VAL ASN LEU CYS ASP ALA MET VAL ASP GLN PRO CME MET SEQRES 14 A 268 ALA PHE SER LEU TYR ASN MET GLY LYS HIS ALA LEU VAL SEQRES 15 A 268 GLY LEU THR GLN SER ALA ALA LEU GLU LEU ALA PRO TYR SEQRES 16 A 268 GLY ILE ARG VAL ASN GLY VAL ALA PRO GLY VAL SER LEU SEQRES 17 A 268 LEU PRO VAL ALA MET GLY GLU GLU GLU LYS ASP LYS TRP SEQRES 18 A 268 ARG ARG LYS VAL PRO LEU GLY ARG ARG GLU ALA SER ALA SEQRES 19 A 268 GLU GLN ILE ALA ASP ALA VAL ILE PHE LEU VAL SER GLY SEQRES 20 A 268 SER ALA GLN TYR ILE THR GLY SER ILE ILE LYS VAL ASP SEQRES 21 A 268 GLY GLY LEU SER LEU VAL HIS ALA SEQRES 1 B 268 MET GLU ALA PRO ALA ALA VAL VAL THR GLY ALA ALA LYS SEQRES 2 B 268 ARG ILE GLY ARG ALA ILE ALA VAL LYS LEU HIS GLN THR SEQRES 3 B 268 GLY TYR ARG VAL VAL ILE HIS TYR HIS ASN SER ALA GLU SEQRES 4 B 268 ALA ALA VAL SER LEU ALA ASP GLU LEU ASN LYS GLU ARG SEQRES 5 B 268 SER ASN THR ALA VAL VAL CYS GLN ALA ASP LEU THR ASN SEQRES 6 B 268 SER ASN VAL LEU PRO ALA SER CYS GLU GLU ILE ILE ASN SEQRES 7 B 268 SER CYS PHE ARG ALA PHE GLY ARG CYS ASP VAL LEU VAL SEQRES 8 B 268 ASN ASN ALA SER ALA PHE TYR PRO THR PRO LEU VAL GLN SEQRES 9 B 268 GLY ASP HIS GLU ASP ASN SER ASN GLY LYS THR VAL GLU SEQRES 10 B 268 THR GLN VAL ALA GLU LEU ILE GLY THR ASN ALA ILE ALA SEQRES 11 B 268 PRO PHE LEU LEU THR MET SER PHE ALA GLN ARG GLN LYS SEQRES 12 B 268 GLY THR ASN PRO ASN CYS THR SER SER ASN LEU SER ILE SEQRES 13 B 268 VAL ASN LEU CYS ASP ALA MET VAL ASP GLN PRO CME MET SEQRES 14 B 268 ALA PHE SER LEU TYR ASN MET GLY LYS HIS ALA LEU VAL SEQRES 15 B 268 GLY LEU THR GLN SER ALA ALA LEU GLU LEU ALA PRO TYR SEQRES 16 B 268 GLY ILE ARG VAL ASN GLY VAL ALA PRO GLY VAL SER LEU SEQRES 17 B 268 LEU PRO VAL ALA MET GLY GLU GLU GLU LYS ASP LYS TRP SEQRES 18 B 268 ARG ARG LYS VAL PRO LEU GLY ARG ARG GLU ALA SER ALA SEQRES 19 B 268 GLU GLN ILE ALA ASP ALA VAL ILE PHE LEU VAL SER GLY SEQRES 20 B 268 SER ALA GLN TYR ILE THR GLY SER ILE ILE LYS VAL ASP SEQRES 21 B 268 GLY GLY LEU SER LEU VAL HIS ALA SEQRES 1 C 268 MET GLU ALA PRO ALA ALA VAL VAL THR GLY ALA ALA LYS SEQRES 2 C 268 ARG ILE GLY ARG ALA ILE ALA VAL LYS LEU HIS GLN THR SEQRES 3 C 268 GLY TYR ARG VAL VAL ILE HIS TYR HIS ASN SER ALA GLU SEQRES 4 C 268 ALA ALA VAL SER LEU ALA ASP GLU LEU ASN LYS GLU ARG SEQRES 5 C 268 SER ASN THR ALA VAL VAL OCS GLN ALA ASP LEU THR ASN SEQRES 6 C 268 SER ASN VAL LEU PRO ALA SER CYS GLU GLU ILE ILE ASN SEQRES 7 C 268 SER CYS PHE ARG ALA PHE GLY ARG CYS ASP VAL LEU VAL SEQRES 8 C 268 ASN ASN ALA SER ALA PHE TYR PRO THR PRO LEU VAL GLN SEQRES 9 C 268 GLY ASP HIS GLU ASP ASN SER ASN GLY LYS THR VAL GLU SEQRES 10 C 268 THR GLN VAL ALA GLU LEU ILE GLY THR ASN ALA ILE ALA SEQRES 11 C 268 PRO PHE LEU LEU THR MET SER PHE ALA GLN ARG GLN LYS SEQRES 12 C 268 GLY THR ASN PRO ASN CYS THR SER SER ASN LEU SER ILE SEQRES 13 C 268 VAL ASN LEU CYS ASP ALA MET VAL ASP GLN PRO CME MET SEQRES 14 C 268 ALA PHE SER LEU TYR ASN MET GLY LYS HIS ALA LEU VAL SEQRES 15 C 268 GLY LEU THR GLN SER ALA ALA LEU GLU LEU ALA PRO TYR SEQRES 16 C 268 GLY ILE ARG VAL ASN GLY VAL ALA PRO GLY VAL SER LEU SEQRES 17 C 268 LEU PRO VAL ALA MET GLY GLU GLU GLU LYS ASP LYS TRP SEQRES 18 C 268 ARG ARG LYS VAL PRO LEU GLY ARG ARG GLU ALA SER ALA SEQRES 19 C 268 GLU GLN ILE ALA ASP ALA VAL ILE PHE LEU VAL SER GLY SEQRES 20 C 268 SER ALA GLN TYR ILE THR GLY SER ILE ILE LYS VAL ASP SEQRES 21 C 268 GLY GLY LEU SER LEU VAL HIS ALA SEQRES 1 D 268 MET GLU ALA PRO ALA ALA VAL VAL THR GLY ALA ALA LYS SEQRES 2 D 268 ARG ILE GLY ARG ALA ILE ALA VAL LYS LEU HIS GLN THR SEQRES 3 D 268 GLY TYR ARG VAL VAL ILE HIS TYR HIS ASN SER ALA GLU SEQRES 4 D 268 ALA ALA VAL SER LEU ALA ASP GLU LEU ASN LYS GLU ARG SEQRES 5 D 268 SER ASN THR ALA VAL VAL CYS GLN ALA ASP LEU THR ASN SEQRES 6 D 268 SER ASN VAL LEU PRO ALA SER CYS GLU GLU ILE ILE ASN SEQRES 7 D 268 SER CYS PHE ARG ALA PHE GLY ARG CYS ASP VAL LEU VAL SEQRES 8 D 268 ASN ASN ALA SER ALA PHE TYR PRO THR PRO LEU VAL GLN SEQRES 9 D 268 GLY ASP HIS GLU ASP ASN SER ASN GLY LYS THR VAL GLU SEQRES 10 D 268 THR GLN VAL ALA GLU LEU ILE GLY THR ASN ALA ILE ALA SEQRES 11 D 268 PRO PHE LEU LEU THR MET SER PHE ALA GLN ARG GLN LYS SEQRES 12 D 268 GLY THR ASN PRO ASN CYS THR SER SER ASN LEU SER ILE SEQRES 13 D 268 VAL ASN LEU CYS ASP ALA MET VAL ASP GLN PRO CME MET SEQRES 14 D 268 ALA PHE SER LEU TYR ASN MET GLY LYS HIS ALA LEU VAL SEQRES 15 D 268 GLY LEU THR GLN SER ALA ALA LEU GLU LEU ALA PRO TYR SEQRES 16 D 268 GLY ILE ARG VAL ASN GLY VAL ALA PRO GLY VAL SER LEU SEQRES 17 D 268 LEU PRO VAL ALA MET GLY GLU GLU GLU LYS ASP LYS TRP SEQRES 18 D 268 ARG ARG LYS VAL PRO LEU GLY ARG ARG GLU ALA SER ALA SEQRES 19 D 268 GLU GLN ILE ALA ASP ALA VAL ILE PHE LEU VAL SER GLY SEQRES 20 D 268 SER ALA GLN TYR ILE THR GLY SER ILE ILE LYS VAL ASP SEQRES 21 D 268 GLY GLY LEU SER LEU VAL HIS ALA MODRES 5IZC CME A 168 CYS MODIFIED RESIDUE MODRES 5IZC CME B 168 CYS MODIFIED RESIDUE MODRES 5IZC OCS C 59 CYS MODIFIED RESIDUE MODRES 5IZC CME C 168 CYS MODIFIED RESIDUE MODRES 5IZC CME D 168 CYS MODIFIED RESIDUE HET CME A 168 10 HET CME B 168 10 HET OCS C 59 9 HET CME C 168 10 HET CME D 168 10 HET NAP A 301 48 HET 6F4 A 302 13 HET ACT A 303 4 HET ACT A 304 4 HET NAP B 301 48 HET 6F4 B 302 13 HET GOL B 303 6 HET NAP C 301 48 HET 6F4 C 302 13 HET ACT C 303 4 HET NAP D 301 48 HET 6F4 D 302 13 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM OCS CYSTEINESULFONIC ACID HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 6F4 N~2~-[(THIOPHEN-2-YL)METHYL]-1,3,4-THIADIAZOLE-2,5- HETNAM 2 6F4 DIAMINE HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 3 OCS C3 H7 N O5 S FORMUL 5 NAP 4(C21 H28 N7 O17 P3) FORMUL 6 6F4 4(C7 H8 N4 S2) FORMUL 7 ACT 3(C2 H3 O2 1-) FORMUL 11 GOL C3 H8 O3 FORMUL 17 HOH *573(H2 O) HELIX 1 AA1 LYS A 13 THR A 26 1 14 HELIX 2 AA2 SER A 37 ARG A 52 1 16 HELIX 3 AA3 VAL A 68 GLY A 85 1 18 HELIX 4 AA4 THR A 115 ALA A 128 1 14 HELIX 5 AA5 ALA A 128 ARG A 141 1 14 HELIX 6 AA6 PHE A 171 ALA A 193 1 23 HELIX 7 AA7 GLY A 214 VAL A 225 1 12 HELIX 8 AA8 SER A 233 SER A 246 1 14 HELIX 9 AA9 GLY A 247 GLN A 250 5 4 HELIX 10 AB1 GLY A 262 VAL A 266 5 5 HELIX 11 AB2 LYS B 13 THR B 26 1 14 HELIX 12 AB3 SER B 37 ARG B 52 1 16 HELIX 13 AB4 VAL B 68 GLY B 85 1 18 HELIX 14 AB5 THR B 115 ALA B 128 1 14 HELIX 15 AB6 ALA B 128 ARG B 141 1 14 HELIX 16 AB7 PHE B 171 ALA B 193 1 23 HELIX 17 AB8 GLY B 214 ARG B 223 1 10 HELIX 18 AB9 SER B 233 SER B 246 1 14 HELIX 19 AC1 GLY B 247 GLN B 250 5 4 HELIX 20 AC2 GLY B 262 VAL B 266 5 5 HELIX 21 AC3 LYS C 13 THR C 26 1 14 HELIX 22 AC4 SER C 37 ARG C 52 1 16 HELIX 23 AC5 VAL C 68 GLY C 85 1 18 HELIX 24 AC6 THR C 115 ALA C 128 1 14 HELIX 25 AC7 ALA C 128 ARG C 141 1 14 HELIX 26 AC8 PHE C 171 ALA C 193 1 23 HELIX 27 AC9 TRP C 221 VAL C 225 5 5 HELIX 28 AD1 SER C 233 SER C 246 1 14 HELIX 29 AD2 GLY C 247 GLN C 250 5 4 HELIX 30 AD3 GLY C 262 VAL C 266 5 5 HELIX 31 AD4 LYS D 13 GLY D 27 1 15 HELIX 32 AD5 SER D 37 ARG D 52 1 16 HELIX 33 AD6 VAL D 68 GLY D 85 1 18 HELIX 34 AD7 THR D 115 ALA D 128 1 14 HELIX 35 AD8 ALA D 128 GLN D 142 1 15 HELIX 36 AD9 PHE D 171 ALA D 193 1 23 HELIX 37 AE1 GLY D 214 VAL D 225 1 12 HELIX 38 AE2 SER D 233 SER D 246 1 14 HELIX 39 AE3 GLY D 247 GLN D 250 5 4 HELIX 40 AE4 GLY D 262 VAL D 266 5 5 SHEET 1 AA1 7 ALA A 56 GLN A 60 0 SHEET 2 AA1 7 ARG A 29 TYR A 34 1 N ILE A 32 O VAL A 57 SHEET 3 AA1 7 ALA A 5 VAL A 8 1 N ALA A 6 O ARG A 29 SHEET 4 AA1 7 VAL A 89 ASN A 92 1 O VAL A 91 N VAL A 7 SHEET 5 AA1 7 LEU A 154 LEU A 159 1 O LEU A 159 N ASN A 92 SHEET 6 AA1 7 ILE A 197 PRO A 204 1 O ASN A 200 N ILE A 156 SHEET 7 AA1 7 ILE A 256 VAL A 259 1 O ILE A 257 N ALA A 203 SHEET 1 AA2 7 ALA B 56 GLN B 60 0 SHEET 2 AA2 7 ARG B 29 TYR B 34 1 N ILE B 32 O VAL B 57 SHEET 3 AA2 7 ALA B 5 VAL B 8 1 N VAL B 8 O HIS B 33 SHEET 4 AA2 7 VAL B 89 ASN B 92 1 O VAL B 91 N VAL B 7 SHEET 5 AA2 7 LEU B 154 LEU B 159 1 O LEU B 159 N ASN B 92 SHEET 6 AA2 7 ILE B 197 PRO B 204 1 O ASN B 200 N ILE B 156 SHEET 7 AA2 7 ILE B 256 VAL B 259 1 O ILE B 257 N ALA B 203 SHEET 1 AA3 7 ALA C 56 GLN C 60 0 SHEET 2 AA3 7 ARG C 29 TYR C 34 1 N ILE C 32 O VAL C 57 SHEET 3 AA3 7 ALA C 5 VAL C 8 1 N ALA C 6 O ARG C 29 SHEET 4 AA3 7 VAL C 89 ASN C 92 1 O VAL C 89 N VAL C 7 SHEET 5 AA3 7 LEU C 154 LEU C 159 1 O VAL C 157 N LEU C 90 SHEET 6 AA3 7 ILE C 197 PRO C 204 1 O ASN C 200 N ASN C 158 SHEET 7 AA3 7 ILE C 256 VAL C 259 1 O VAL C 259 N ALA C 203 SHEET 1 AA4 7 ALA D 56 GLN D 60 0 SHEET 2 AA4 7 ARG D 29 TYR D 34 1 N ILE D 32 O VAL D 57 SHEET 3 AA4 7 ALA D 5 VAL D 8 1 N ALA D 6 O ARG D 29 SHEET 4 AA4 7 VAL D 89 ASN D 92 1 O VAL D 91 N VAL D 7 SHEET 5 AA4 7 LEU D 154 LEU D 159 1 O LEU D 159 N ASN D 92 SHEET 6 AA4 7 ILE D 197 PRO D 204 1 O ARG D 198 N ILE D 156 SHEET 7 AA4 7 ILE D 256 VAL D 259 1 O VAL D 259 N ALA D 203 LINK C PRO A 167 N CME A 168 1555 1555 1.34 LINK C CME A 168 N MET A 169 1555 1555 1.30 LINK C PRO B 167 N CME B 168 1555 1555 1.34 LINK C CME B 168 N MET B 169 1555 1555 1.31 LINK C VAL C 58 N OCS C 59 1555 1555 1.35 LINK C OCS C 59 N GLN C 60 1555 1555 1.35 LINK C PRO C 167 N CME C 168 1555 1555 1.35 LINK C CME C 168 N MET C 169 1555 1555 1.31 LINK C PRO D 167 N CME D 168 1555 1555 1.33 LINK C CME D 168 N MET D 169 1555 1555 1.31 SITE 1 AC1 33 LYS A 13 ARG A 14 ILE A 15 TYR A 34 SITE 2 AC1 33 HIS A 35 ASN A 36 SER A 37 ALA A 61 SITE 3 AC1 33 ASP A 62 LEU A 63 THR A 64 ASN A 93 SITE 4 AC1 33 ALA A 94 SER A 95 THR A 126 LEU A 159 SITE 5 AC1 33 CYS A 160 TYR A 174 LYS A 178 PRO A 204 SITE 6 AC1 33 GLY A 205 SER A 207 LEU A 208 6F4 A 302 SITE 7 AC1 33 HOH A 404 HOH A 412 HOH A 414 HOH A 420 SITE 8 AC1 33 HOH A 427 HOH A 455 HOH A 482 HOH A 495 SITE 9 AC1 33 HOH A 503 SITE 1 AC2 6 SER A 95 PHE A 97 CME A 168 TYR A 174 SITE 2 AC2 6 PRO A 210 NAP A 301 SITE 1 AC3 3 ARG A 14 ARG A 17 HOH A 413 SITE 1 AC4 2 ASN A 65 ASN C 65 SITE 1 AC5 31 ARG B 14 ILE B 15 TYR B 34 HIS B 35 SITE 2 AC5 31 ASN B 36 SER B 37 ALA B 61 ASP B 62 SITE 3 AC5 31 LEU B 63 THR B 64 ASN B 93 ALA B 94 SITE 4 AC5 31 SER B 95 THR B 126 LEU B 159 CYS B 160 SITE 5 AC5 31 TYR B 174 LYS B 178 PRO B 204 GLY B 205 SITE 6 AC5 31 SER B 207 LEU B 208 6F4 B 302 HOH B 431 SITE 7 AC5 31 HOH B 437 HOH B 439 HOH B 441 HOH B 456 SITE 8 AC5 31 HOH B 474 HOH B 514 HOH B 528 SITE 1 AC6 6 SER B 95 PHE B 97 TYR B 174 VAL B 206 SITE 2 AC6 6 NAP B 301 HOH B 414 SITE 1 AC7 8 ASP B 46 VAL B 57 VAL B 58 TYR C 34 SITE 2 AC7 8 OCS C 59 GLN C 60 ARG C 82 HOH C 418 SITE 1 AC8 31 ARG C 14 ILE C 15 TYR C 34 HIS C 35 SITE 2 AC8 31 ASN C 36 SER C 37 ALA C 61 ASP C 62 SITE 3 AC8 31 LEU C 63 THR C 64 ASN C 93 ALA C 94 SITE 4 AC8 31 SER C 95 THR C 126 LEU C 159 CYS C 160 SITE 5 AC8 31 TYR C 174 LYS C 178 PRO C 204 GLY C 205 SITE 6 AC8 31 SER C 207 LEU C 208 6F4 C 302 HOH C 410 SITE 7 AC8 31 HOH C 424 HOH C 425 HOH C 457 HOH C 469 SITE 8 AC8 31 HOH C 477 HOH C 497 HOH C 502 SITE 1 AC9 9 SER C 95 PHE C 97 CME C 168 TYR C 174 SITE 2 AC9 9 VAL C 206 LEU C 209 PRO C 210 TRP C 221 SITE 3 AC9 9 NAP C 301 SITE 1 AD1 5 TYR B 34 VAL B 58 VAL C 57 VAL C 58 SITE 2 AD1 5 HOH C 418 SITE 1 AD2 31 ARG D 14 ILE D 15 TYR D 34 HIS D 35 SITE 2 AD2 31 ASN D 36 SER D 37 ALA D 61 ASP D 62 SITE 3 AD2 31 LEU D 63 THR D 64 ASN D 93 ALA D 94 SITE 4 AD2 31 SER D 95 THR D 126 LEU D 159 CYS D 160 SITE 5 AD2 31 TYR D 174 LYS D 178 PRO D 204 GLY D 205 SITE 6 AD2 31 SER D 207 LEU D 208 6F4 D 302 HOH D 402 SITE 7 AD2 31 HOH D 412 HOH D 413 HOH D 422 HOH D 435 SITE 8 AD2 31 HOH D 483 HOH D 488 HOH D 493 SITE 1 AD3 8 SER D 95 PHE D 97 CME D 168 TYR D 174 SITE 2 AD3 8 VAL D 206 PRO D 210 MET D 213 NAP D 301 CRYST1 74.630 89.443 82.645 90.00 115.87 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013399 0.000000 0.006497 0.00000 SCALE2 0.000000 0.011180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013447 0.00000